Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
24.65
+1.13 (4.80%)
At close: Jan 23, 2025, 4:00 PM
24.87
+0.22 (0.91%)
After-hours: Jan 23, 2025, 7:58 PM EST
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $18.18 billion as of January 23, 2025. Its market cap has increased by 917.18% in one year.
Market Cap
18.18B
Enterprise Value
17.72B
1-Year Change
917.18%
Ranking
Category
Stock Price
$24.65
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $18.18B, an increase of 15,175.71%. That is a compound annual growth rate of 66.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 22, 2025 | 17.34B | 31.80% |
Dec 31, 2024 | 13.16B | 619.43% |
Dec 29, 2023 | 1.83B | 113.79% |
Dec 30, 2022 | 855.60M | 225.45% |
Dec 31, 2021 | 262.90M | -32.00% |
Dec 31, 2020 | 386.60M | 653.61% |
Dec 31, 2019 | 51.30M | 203.55% |
Dec 31, 2018 | 16.90M | -87.66% |
Dec 29, 2017 | 137.00M | 30.60% |
Dec 30, 2016 | 104.90M | -21.83% |
Dec 31, 2015 | 134.20M | 12.77% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 677.63B |
UnitedHealth Group | 484.33B |
Novo Nordisk | 360.47B |
Johnson & Johnson | 354.32B |
AbbVie | 298.79B |
Merck & Co. | 242.01B |
Thermo Fisher Scientific | 216.42B |
Intuitive Surgical | 215.42B |